geoopen
Neoadjuvant and adjuvant pembrolizumab for advanced high-grade serous carcinoma (NeoPembrOV): A randomized phase II GINECO clinical trial
GEO Series GSE227666. Homo sapiens. 109 samples. Type: Expression profiling by high throughput sequencing.
ShareScore
16/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 4
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4